Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study

Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study

Abstract Background Acute respiratory distress syndrome (ARDS) is caused by rapid-onset (within hours) acute inflammatory processes in lung tissue, and it is a life-threatening condition with high mortality. The treatment of ARDS to date is focused on the prevention of further iatrogenic damage of t...

Full description

Bibliographic Details
Main Authors: Helene Haeberle, Stefanie Prohaska, Peter Martus, Andreas Straub, Alexander Zarbock, Gernot Marx, Manola Zago, Martin Giera, Michael Koeppen, Peter Rosenberger
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Trials
Subjects:
ARDS
Iloprost
Inflammation
Intensive care
Ventilation
Online Access:http://link.springer.com/article/10.1186/s13063-020-4163-0

Internet

http://link.springer.com/article/10.1186/s13063-020-4163-0

Similar Items